Your browser doesn't support javascript.
loading
Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy.
Wu, Jianghua; Tang, Lu; Du, Mengyi; Li, Chenggong; Kou, Haiming; Jiang, Huiwen; Luo, Wenjing; Zhang, Yinqiang; Huang, Zhongpei; Liao, Danying; Xiong, Wei; Mei, Heng; Hu, Yu.
Afiliação
  • Wu J; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tang L; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Du M; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li C; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Kou H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Jiang H; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Luo W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang Y; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Huang Z; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liao D; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Xiong W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mei H; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.
  • Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Clin Transl Med ; 13(3): e1225, 2023 03.
Article em En | MEDLINE | ID: mdl-36938989

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China